Investigating how GPR56 affects kidney cell injury in early diabetes-related kidney disease
Role of GPR56 in glomerular endothelial cell injury in early diabetic kidney disease
['FUNDING_CAREER'] · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · NIH-11013319
This study is looking at how a specific protein called GPR56 affects kidney cells during the early stages of diabetic kidney disease, with the hope of finding new ways to help people with this condition.
Quick facts
| Phase | ['FUNDING_CAREER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-11013319 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding the role of GPR56, a specific receptor, in the injury of glomerular endothelial cells (GECs) during the early stages of diabetic kidney disease (DKD). By isolating GECs from genetically modified mice, researchers will analyze the differences in gene expression between diabetic and non-diabetic cells using advanced techniques like RNA sequencing. The goal is to uncover the mechanisms behind GEC dysfunction, which could lead to early therapeutic interventions for patients with DKD.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with early-stage diabetic kidney disease.
Not a fit: Patients with advanced diabetic kidney disease or those without diabetes are unlikely to benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent or slow the progression of diabetic kidney disease.
How similar studies have performed: Previous research has shown promising results in understanding endothelial cell dysfunction in diabetic conditions, suggesting that this approach could yield valuable insights.
Where this research is happening
NEW YORK, UNITED STATES
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FU, JIA — ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
- Study coordinator: FU, JIA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.